Cystamine and its reduced form cysteamine showed protective effects in various models of neurodegenerative disease, including Huntington's disease and Parkinson's disease. Other lines of evidence demonstrated the cytotoxic effect of cysteamine on duodenal mucosa leading to ulcer development. However, the mechanism for cystamine cytotoxicity remains poorly understood. Here, we report a new pathway in which cystamine induces apoptosis by targeting apoptosis-inducing factor (AIF). By screening of various cell lines, we observed that cystamine and cysteamine induce cell death in a cell type-specific manner. Comparison between cystamine-sensitive and cystamine-resistant cell lines revealed that cystamine cytotoxicity is not associated with unfolded protein response, reactive oxygen species generation and transglutaminase or caspase activity; rather, it is associated with the ability of cystamine to trigger AIF nuclear translocation. In cystamine-sensitive cells, cystamine suppresses the levels of intracellular glutathione by inhibiting γ-glutamylcysteine synthetase expression that triggers AIF translocation. Conversely, glutathione supplementation completely prevents cystamine-induced AIF translocation and apoptosis. In rats, cysteamine administration induces glutathione depletion and AIF translocation leading to apoptosis of duodenal epithelium. These results indicate that AIF translocation through glutathione depletion is the molecular mechanism of cystamine toxicity, and provide important implications for cystamine in the neurodegenerative disease therapeutics as well as in the regulation of AIF-mediated cell death.
Introduction
Cystamine is a disulfide amine that has antioxidative capacity and alters cellular antioxidant system [1] [2] [3] . Under intracellular conditions, cystamine is in equilibrium with its reduced form cysteamine which has a direct antioxidant effect [4] [5] [6] . In neuronal tissue, cystamine protected against cell death in several disease models that are thought to be associated with oxidative stress, including Huntington's disease [7, 8] , Parkinson's disease [9, 10] , dentatorubral-pallidoluysian atrophy [11] and neuropsychiatric systemic lupus erythematosus [12] . Thus, therapeutic effect of cysteamine for patients with Huntington's disease has been tested in clinical trial [13] . In addition to the role of cystamine as an antioxidant, other mechanisms have been proposed for its neuroprotective effect. It has been shown that cystamine modulates the apoptotic process by inhibition of enzymes such as caspase-3 and transglutaminases [3, 5, 14] . Moreover, cystamine is also involved in the regulation of cellular responsiveness to oxidative stress. It has been reported that cystamine increases the expression levels of heatshock protein [8] , brain-derived neurotrophic factor [15] and glutathione transferase A3 [16] . These observations indicate that cystamine directly or indirectly suppresses oxidative stress-induced neuronal cell death.
However, other lines of evidence demonstrated that cystamine promotes oxidative stress-induced cell death in other type of cells, especially in intestinal epithelium, by inhibition of γ-glutamylcysteine synthetase (GCS), a key enzyme for glutathione (GSH) synthesis [2, 17] . Cystamine is known to inhibit GCS through a sulfhydryl-disulfide interchange reaction between sulfhydryl groups at or around the active site of the GCS and cystamine [6] , and the reduced form cysteamine also acts as a competitive inhibitor [5] . Indeed, Vanin-1, a cysteamine synthesizing enzyme, deficient mice showed no detectable free cysteamine and increased levels of intracellular GSH in intestinal epithelium [18, 19] . Consequently, these mice were resistant to oxidative stress and inflammation, and deficient phenotypes were reversed by cystamine administration [6, 19] . Moreover, cysteamine administration induces cell death of duodenal mucosal cells [20] , possibly by generating hydrogen peroxides [19] , resulting in perforating ulcers in rat. This rat model of cysteamine-induced duodenal ulcer is easily reproducible and similar to human duodenal ulcer, and thus has been used for studying the pathogenesis of duodenal ulceration. The concentration of cysteamine used in rat duodenal ulcer model (intragastric, 250 mg/kg three times at 4 h intervals) was similar to the concentration of cystamine in mouse neurodegenerative disease models (intraperitoneally, 100-750 mg/kg) [7, 9, 20] . These observations indicate that the effect of cystamine on cell survival is partly dependent on cell-type, and that investigation on the mechanism for cystamine cytotoxicity is needed for re-evaluating cystamine as a new medication for neurodegenerative diseases as well as for better understanding of the etiology of duodenal ulceration.
GSH is the most important non-protein antioxidant and has a critical role in maintaining cellular redox status. Under physiological conditions, intracellular GSH concentrations range from 1 to 11 mM. Although GCS expression and activity is tightly regulated at different levels to maintain GSH concentration [21] , GSH is depleted by increased oxidative stress or treatment with apoptotic agents such as death receptor ligands or chemotherapeutics [22] . Thus, the level of intracellular GSH is considered to be a marker for cellular redox status during oxidative stress-induced cell death. However, it is also known that GSH depletion per se induces cell death. GCS deficient mice displayed embryonic lethality due to a massive cell death [23] . Pharmacological inhibition of GCS with buthionine sulfoximine (BSO) induces or stimulates cell death [24, 25] . Moreover, GSH depletion is required for Fas ligandinduced apoptosis regardless of reactive oxygen species (ROS) generation and oxidative stress [26] , suggesting a previously unidentified mechanism for oxidative stress-induced cell death.
Apoptosis-inducing factor (AIF) is a flavoprotein that is located in the mitochondrial intermembrane space and plays major roles in mediating caspase-independent cell death [27] . Upon cell death stimuli, AIF is cleaved within the mitochondria by calpains and cathepsins [28] , released into cytosol possibly through a mitochondrial permeability transition pore, and translocated into the nucleus where it induces chromatin condensation and DNA fragmentation through complex formation with H2AX and cyclophilin A [29, 30] . A number of apoptotic stimuli have been documented to induce AIF mitochondria-to-nucleus translocation including DNA damaging agents, hypoxia/ischemia, oxidative stress and excitotoxins such as glutamate [27] . However, the signaling pathways that cause AIF nuclear translocation have not been fully elucidated.
In this study, we examined the cystamine cytotoxicity in various tumor cell lines, and found that cystamine induces caspaseindependent cell death in a cell-type specific manner. In cystaminesensitive cell lines, cystamine causes the depletion of intracellular GSH which triggers AIF nuclear translocation. These results were verified in a rat model of cysteamine-induced duodenal ulcer.
Materials and methods

Cell culture
DU145, human prostate cancer cells and HeLa, human cervical cancer cells were maintained in Dulbecco's modified Eagle medium (WelGENE, Daegu, Korea) containing 10% heat-inactivated fetal bovine serum (Hyclone, Logan, UT, USA). The neuroblastoma cells, SK-N-SH and SH-SY-5Y were also cultured in Dulbecco's modified Eagle medium. MCF7, human breast cancer cells and A549, human lung cancer cells were maintained in RPMI 1640 medium (WelGENE) containing 10% heat-inactivated fetal bovine serum. Penicillin (100 U/ml; Invitrogen, Carlsbad, CA, USA), streptomycin sulfate (100 μg/ml; Invitrogen) and glutamine (2 mM; Invitrogen) were supplemented to all cell culture media. All cells were maintained in a humidified incubator with 5% CO 2 at 37°C.
All cells were grown to 20% confluence and then treated with cystamine, cysteamine, dithiothreitol (DTT; ICN Biomedicals Inc., Aurora, OH, USA) or β-mercaptoethanol (β-ME; Merck, Darmstadt, Germany) for 72 h. Parallel groups of cells were pretreated with N-acetylcysteine (NAC), vitamin C, vitamin E, Trolox (6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid), quercetin, glutathione ethyl ester (GSH-EE), BSO or z-VAD-fmk for 1 h prior to addition of cystamine or cysteamine. Cells were pretreated with polyethylene glycol (PEG)-conjugated catalase for 4 h. All chemicals were purchased from Sigma-Aldrich Corporation (St. Louis, MO, USA) unless otherwise indicated.
HeLa cell lines expressing shRNA of transglutaminase 2 (TG2; HeLa shTG2 ) were established by transfection with pSUPER plasmid containing shRNA for TG2 as described previously [31] . For knock-down of AIF, HeLa cells were transfected with siRNA for AIF (Santa Cruz Biotechnology, Santa Cruz, CA, USA) using Lipofectamine 2000 (Invitrogen) according to the manufacturer's instructions. The expression of TG2 and AIF was confirmed by Western blot analysis.
MTT colorimetric assay
Cells were cultured to 20% confluence on 24-well dishes and treated with cystamine, cysteamine, DTT or β-ME for the indicated times. After washing with phosphate buffered saline (PBS), cells were incubated for 4 h in MTT solution (500 μg/ml of tetrazolium MTT (3-(4,5dimethylthiazolyl-2)-2,5-diphenyltetrazolium bromide; Sigma-Aldrich Corporation) in culture medium). MTT solution was removed, and dimethyl sulfoxide (DMSO) was added to dissolve the formazan crystals. The 24-well dishes were slightly vortexed and incubated in the dark. Samples were diluted to proper concentration and transferred to a 96-well plate. The absorbance at 570 nm in each well was measured by a microplate spectrophotometer. Values for untreated controls were set at 100% cell viability, and each treatment was assessed as a percentage of the control values. Each treatment was performed in triplicate.
Lactate dehydrogenase release assay
Lactate dehydrogenase (LDH) released to culture medium was estimated using CytoTox 96 Non-radioactive Cytotoxicity Assay (Promega, Madison, WI, USA) according to the manufacturer's instruction. Cells were treated with cystamine or cysteamine for 72 h, and 50 μl of culture media was transferred to the 96-well plate. After the addition of 50 μl of LDH substrate reagent to each well, the plate was incubated for 30 min in the dark and 50 μl of stop solution was added. The absorbance at 490 nm was measured by the microplate spectrophotometer. The background values were subtracted, and each treatment was assessed as a percentage of the untreated control values. Each treatment was performed in triplicate.
In situ transglutaminase (TG) activity assay
Cells were incubated for 1 h with 1 mM 5-biotinamidopentylamine (BP; Pierce, Rockford, IL, USA) and harvested by centrifugation. The cells were ruptured by sonication, followed by centrifugation (14 000 g, 10 min at 4°C). The cellular proteins (10 μg/well) in coating buffer (50 mM Tris-Cl, pH 7.5, 150 mM NaCl, 5 mM EGTA, 5 mM EDTA) were added to each well of a 96-well microtiter plate. In situ TG activity was estimated by measuring the amount of BP that is incorporated into the proteins. The BP-incorporated products were probed using horseradish peroxidase-conjugated streptavidin (Zymed Laboratories, South San Francisco, CA, USA) followed by a reaction with o-phenylenediamine dihydrochloride (Sigma-Aldrich Corporation). After incubation for 5 to 10 min at room temperature, the reaction was stopped by the addition of H 2 SO 4 . The absorbance at 490 nm was measured by the microplate spectrophotometer.
ROS detection using dichlorofluorescein (DCF)
For measurement of the ROS generation, cells were harvested by centrifugation and incubated with 40 μM DCF in KRH buffer (10 mM HEPES, pH 7.4, 150 mM NaCl, 6 mM KCl, 1 mM MgCl 2 ) containing 0.2% bovine serum albumin (BSA) and 1 μg/μl glucose for 30 min at 37°C. After washing, cells were then analyzed by flow cytometry (Becton Dickinson, San Jose, CA, USA) with 488 nm excitation and 535 nm emission filters. Data analysis was performed using the ModFit LT V3.0 software (Verity Software House, Topsham, ME, USA).
Analysis of cellular DNA content by PI staining
Cells were treated with 500 μM cystamine for 72 h and were harvested by trypsinization. After washing with PBS, cells (~1 × 10 6 ) were fixed in 1 ml of 70% ethanol at 4°C for overnight and resuspended in 200 μl of PBS containing 50 μg/ml propidium iodide and 100 μg/ml RNase A. After incubating for 30 min in the dark at room temperature, cells were then analyzed by flow cytometry (Becton Dickinson) with 488 nm excitation and 610 nm emission filters.
Mitochondrial membrane potential
Mitochondria membrane potential was evaluated using the lipophilic cationic probe JC-1 (Invitrogen) according to the manufacturer's instruction. Cells were harvested and resuspended in PBS. After adding 2 μM JC-1, cells were incubated for 30 min at 37°C with rotation. Cells were washed with PBS and analyzed by flow cytometry (Becton Dickinson) using 488 nm excitation with emission filters appropriate for 515 nm and 580 nm.
Confocal microscopy
After being treated with cystamine or cysteamine for 72 h, cells were washed with cold PBS. The cells were fixed with 4% formaldehyde in PBS for 15 min at room temperature, and then permeabilized with 0.1% Triton X-100 in PBS for 5 min at room temperature followed by blocking with 1% BSA in PBST (PBS containing 0.1% Tween-20) for 30 min. AIF was labeled by an anti-AIF antibody (Santa Cruz Biotechnology) diluted in PBST and fluorescently labeled by 20 μg/ml of FITC-conjugated goat anti-mouse IgG (Molecular Probes, Eugene, OR, USA) in PBS containing 1% BSA for 1 h. Nucleus was labeled by 1 μg/ml of DAPI (Roche, Mannheim, Germany) in the solution. A confocal fluorescence microscope (LSM 510 META; Carl Zeiss, Oberkochen, Germany) was used to visualize the each sample.
Caspase-3-like and caspase-9-like activity assay
Caspase activity was measured by using chromogenic substrates, Ac-DEVD-pNA for caspase-3-like activity and Ac-LEHD-pNA for caspase-9like activity (A.G. Scientific Inc., San Diego, CA, USA), as previously described with minor modification [32] . Cells were harvested and lysed in buffer (50 mM HEPES, pH 7.4, 0.1% CHAPS, 1 mM DTT, 0.1 mM EDTA and 0.1% Triton X-100) for 30 min followed by centrifugation at 12000 g for 10 min at 4°C. The protein concentration in the supernatant was quantitated by the BCA method (Pierce). The cell extract (50 μg of protein) was added to assay buffer (100 mM HEPES, pH 7.4, 0.1% CHAPS, 10 mM DTT, 10% glycerol and 2% (v/v) DMSO) containing 2 mM chromogenic substrates and incubated for 4 h at 37°C. Caspase activity was quantified by measuring the absorbance at 405 nm on microplate spectrophotometer. Caspase activity is calculated as described in the protocol for the CaspACE™ Assay System Kit (Promega) and each treatment was assessed as a percentage of the untreated control values.
Western blot analysis
Cells were sonicated in buffer (50 mM Tris-Cl, pH 7.4, 150 mM NaCl, 1% Triton X-100, protease inhibitor cocktail (Roche) and phosphatase inhibitor cocktail (Roche)) and centrifuged 20000 g for 10 min at 4°C. After determination of protein concentration in the cell extract by the BCA method, 40 μg of protein was resolved by SDS-PAGE and transferred to a nitrocellulose membrane. Membranes were blocked for 1 h with 5% skim milk in Tris-buffered saline, and incubated with anti-TG2 [33] , anti-AIF (Santa Cruz Biotechnology), anti-GCS C (catalytic subunit of GCS; Santa Cruz Biotechnology) and anti-Actin (Sigma-Aldrich Corporation) antibodies. The membranes were washed and incubated with horseradish peroxidase-conjugated secondary antibody, followed by enhanced chemiluminescence development according to the manufacturer's instruction (Pierce).
Measurement of glutathione concentration
GSH concentration was estimated by using a GSH assay kit (Cayman Chemical Co., Ann Arbor, MI, USA). Briefly, cells and tissues were lysed in buffer (50 mM Tris-Cl, pH 7.4, 150 mM NaCl, 1% Triton X-100), and centrifuged 10 000 g for 15 min. After determination of protein concentration by the BCA method, cell lysates were subjected to sequential treatment of 5% (w/v) metaphosphoric acid (Sigma-Aldrich Corporation) and 0.1 M triethanolamine (Sigma-Aldrich Corporation). Deproteinized samples were mixed with a solution containing 5,5′dithio-bis-2-nitrobenzoic acid (DTNB), and 5-thio-2-nitrobenzoic acid (TNB) produced by a reaction between the sulfhydryl groups of GSH and DTNB was estimated by measuring absorbance at 405 or 412 nm. Total GSH and oxidized GSH concentrations were determined after treatment of the samples with GSH reductase and 10 mM 2-vinylpyridine (Sigma-Aldrich Corporation), respectively. Reduced GSH was calculated by subtraction of oxidized GSH from total GSH.
Duodenal ulcer model in rat
All animal procedures were approved by the Institutional Animal Care and Use Committee at the Seoul National University College of Medicine (IACUC Approval No. SNU-130624-1). Duodenal ulcers were induced in female Sprague-Dawley rats aged 6-8 weeks (Orient, Seoul, Korea) by intragastric administration of cysteamine as previously reported [34] . Cysteamine (25 mg/100 g body weight, Sigma-Aldrich Corporation) was given three times at 4 h intervals. Rats were euthanized at 10 or 24 h after the first dose of cysteamine and duodenums were collected for estimation of GSH content and immunofluorescence staining.
Statistical analysis
All statistical calculations were performed using Prism 4.0 (GraphPad, San Diego, CA, USA). Differences between two variables and multiple variables were assessed by unpaired Student's t test and one-way ANOVA with Tukey's multiple comparison test, respectively. The difference was considered significant if the p value was less than 0.05.
Results
Cystamine and cysteamine induce tumor cell-type specific cell death
To evaluate cystamine toxicity, we treated the DU145, HeLa, MCF7 and A549 cell lines with various cystamine concentrations for 72 h. Interestingly, we discovered that cystamine treatment resulted in a dose-and time-dependent cytotoxicity in the DU145 and HeLa cell lines but showed no effect in the MCF7 and A549 cell lines ( Fig. 1a-d ).
In addition, neuroblastoma cells (SK-N-SH and SH-SY-5Y) were also resistant to cystamine treatment (Fig. 1e ). Cystamine is reduced into two cysteamine molecules in the cytosol. To determine whether the cytotoxicity was caused by cystamine or its reduced form cysteamine, we also evaluated cysteamine toxicity in DU145 cells. Both MTT and LDH release assays demonstrated that cysteamine also induced cell death in a dose-dependent manner, and half of the cystamine dose was required to induce a similar rate of cell death compared to cysteaminetreated cells (Fig. 1f, g) , indicating that cysteamine is responsible for cell type-specific cytotoxicity.
Cystamine cytotoxicity is not associated with unfolded protein response, ROS generation or TG2 activity
We investigated the mechanisms for cystamine cytotoxicity. Cysteamine is a reducing agent that could induce cell death by eliciting unfolded protein response [35] . To test this possibility, we examined the sensitivity of cell lines to DTT and β-ME. There was no significant difference in cell viability among the cystamine-sensitive and -resistant cells ( Fig. 2a, b) , indicating that cystamine cytotoxicity is not caused by unfolded protein response.
Cysteamine produces H 2 O 2 by reaction of the thiol group with metal ions [36] . To assess this possibility, we measured ROS levels in DU145 cells using DCF dye. Cystamine or cysteamine treatment reduced, rather than increased, fluorescence intensity (Fig. 2c ). Antioxidants such as vitamin C, vitamin E, Trolox and quercetin had no effect on cystamine toxicity. Interestingly, only NAC abrogated cystamine toxicity (Fig. 2d ). Moreover, exogenous H 2 O 2 was more toxic to MCF7 and A549 cells than DU145 and HeLa cells (data not shown), and addition of polyethylene glycol (PEG)-conjugated catalase had little effect on cystamine sensitivity ( Fig. 2e ), suggesting that H 2 O 2 generation did not contribute to cystamine cytotoxicity.
TG2 suppresses oxidative stress-induced apoptosis through crosslinking of caspase-3 and IκB [37] , and cystamine inhibits TG2 by a thiol-disulfide exchange reaction [36] . To test whether TG2 might participate in cystamine toxicity, we compared TG2 protein levels and its intracellular activity among cell lines. TG2 expression levels were variable and not correlated with cystamine sensitivity (Fig. 2f) . In situ TG activity in DU145 and HeLa cells was higher than that in MCF7 and A549 cells (Fig. 2f) , and down-regulation of TG2 by shRNA in HeLa cells had no effects on cystamine sensitivity (Fig. 2g) . These results indicate that cystamine cytotoxicity was not due to TG2 activity inhibition.
Cystamine-induced cell death depends on intracellular GSH levels
Cystamine treatment decreases cellular GSH level through GCS inhibition [2, 19] . We therefore speculated that cell-type specific cystamineinduced cell death may be explained by a difference in the ability of the cells to synthesize GSH. To test this hypothesis, we monitored GSH levels. Upon cystamine treatment, total and reduced GSH levels in cystamine-sensitive cells (DU145 and HeLa) were maintained for 24 h but decreased thereafter. In contrast, GSH levels in cystamine-resistant cells (MCF7 and A549) were increased approximately 1.8-to 2.2-fold after 24 h, and basal GSH levels were maintained even in the presence of cystamine (Fig. 3a, b) , demonstrating that GSH levels are well correlated with cystamine susceptibility. We next assessed whether GCS protein levels are important in regulating intracellular GSH levels. Western blot analysis revealed that in cystamine-sensitive cells, GCS levels were increased during the initial 24 h of cystamine treatment, but decreased abruptly after 48 or 72 h (Fig. 3c) , whereas in cystamine-resistant cells, basal GCS levels were maintained for 72 h (Fig. 3d) , indicating that GCS expression is correlated with intracellular GSH levels and a major determinant of cystamine sensitivity. We asked whether augmenting intracellular GSH levels could prevent cystamine-induced cell death. In cystamine-treated DU145 and HeLa cells, GSH-EE supplementation completely rescued cystamineinduced cell death (Fig. 3e) . Conversely, GSH synthesis inhibition by BSO treatment rendered MCF7 and A549 cells cystamine-sensitive ( Fig. 3f) , demonstrating that GSH depletion is critical for triggering cell death.
Cystamine induces caspase-independent cell death
To gain insight into the mechanisms of cystamine cytotoxicity, we investigated the morphological and biochemical features of cystamine-induced cell death [38] . We examined the effect of cystamine on DNA fragmentation by staining with propidium iodide. Flow cytometric analysis revealed that cystamine treatment resulted in approximately a 3-fold increase of the SubG1 fraction in DU145 cells compared with control cells (Fig. 4a ). When stained with DAPI, cystamine-or cysteamine-treated cells displayed condensed chromatin compared with control cells (Fig. 4b ). Moreover, cystamine or cysteamine evoked mitochondrial membrane depolarization (Fig. 4c) . These features were prevented by NAC (Fig. 4a-c) . However, when caspase-3-like and -9-like activities were measured, we found no increase in either caspase activity in cystamine-treated cells (Fig. 4d ). Furthermore, the caspase inhibitor z-VAD-fmk did not affect cystamine cytotoxicity (Fig. 4e) , implying that cystamine-induced cell death is independent of caspase activity.
Cystamine induces AIF nuclear translocation in a cell-type specific manner
AIF is a mitochondrial flavoprotein that plays a major role in caspase-independent cell death [28] . Confocal microscopic analyses revealed that cystamine induced AIF nuclear translocation only in DU145 and HeLa cells, but not in MCF7 and A549 cells (Fig. 5a ). Moreover, cystamine-induced AIF nuclear translocation was completely blocked by NAC (Fig. 5b) . To further confirm the causal role of AIF in cystamine-induced cell death, we compared the cystamine cytotoxicity in wild-type and AIF-downregulated cells. AIF knockdown by siRNA decreased the cell death in cystamine-treated cells, demonstrating an inverse relationship between AIF expression and cystamine cytotoxicity (Fig. 5c ). These results indicate that cystamine induces cell death via AIF nuclear translocation.
We next tested the possibility that GSH depletion below a certain level may trigger AIF nuclear translocation. In cystamine-treated DU145 and HeLa cells, immunocytochemical staining demonstrated that GSH-EE treatment prevented cystamine-induced AIF nuclear translocation ( Fig. 6) , indicating that GSH depletion is critical for triggering AIF nuclear translocation.
Cystamine-induced AIF translocation is not associated with calpain I and PARP-1
Calpain I and poly (ADP-ribose) polymerase-1 (PARP-1) are involved in AIF nuclear translocation by various apoptogenic stimuli [28] . To assess whether these enzymes are also required for cystamine-induced AIF translocation, we treated DU145 and HeLa cells with the calpain inhibitor ALLN or the PARP-1 inhibitor DPQ (3,4-dihydro-5-[4-(1piperidinyl)butoxy]-1(2H)-isoquinolinone), and we found that these enzyme inhibitors had no effect on cystamine-induced cell death in both cell lines (Fig. 7a, b ), suggesting that GSH depletion might be a new pathway for promoting AIF nuclear translocation.
Cysteamine induces AIF-mediated apoptosis in a rat model of duodenal ulcer
We next sought to extend these results from cellular models to an in vivo model of cysteamine toxicity. In rat, cysteamine is a wellknown chemical to induce perforating duodenal ulcer in the proximal duodenum after 24-48 h of administration [20, 34] . We tested whether intragastric administration of cysteamine could induce apoptosis of duodenal epithelial cells by depleting GSH and triggering AIF nuclear translocation. Female Sprague-Dawley rats received cysteamine (25 mg/100 g body weight) three times at 4 h intervals. Duodenal ulcer was developed within 48 h in all animals receiving cysteamine. When GSH levels were determined in the duodenal tissues, total GSH concentrations were decreased after 10 h which were restored after 24 h of cysteamine administration (Fig. 8a) . Concurrently, immunofluorescence staining of AIF revealed that AIF was translocated into the nucleus of duodenal epithelium after 24 h of cysteamine administration (Fig. 8b) , indicating that AIF translocation caused by GSH depletion may be a relevant molecular mechanism for cysteamine-induced duodenal ulcer in rat.
Discussion
In the present study, we investigated cystamine toxicity and found that cystamine induced caspase-independent cell death in a cell type-specific manner. Comparison between cystamine-sensitive and -resistant cells demonstrated that cystamine-induced cell death is caused by AIF nuclear translocation. Subsequent analyses identified the decreased GSH levels as a triggering factor for AIF translocation. A causal role of GSH depletion is demonstrated by the observations that GSH supplementation completely prevented AIF nuclear translocation. Moreover, these results from cellular models were verified in a rat model of cysteamine-induced duodenal ulcer. Our data also demonstrated that cystamine cytotoxicity is not associated with its ability to induce unfolded protein response, to generate ROS, or to inhibit TG2 activity. Collectively, our results indicate that AIF nuclear translocation induced by GSH depletion is a critical molecular event in cystamine toxicity.
Cysteamine is an intracellular reduced form of cystamine and is synthesized from pantetheine by membrane-anchored pantetheinase, an enzyme encoded by the widely expressed vanin gene family. Cysteamine is catabolized to hypotaurine and taurine by cysteamine dioxygenase [18, 39] . The concentrations of cystamine and cysteamine in brain and plasma are very low (under the detection limit) [40] , and the molecular mechanism of transport of cystamine and cysteamine into cells has not been revealed yet. Although cysteamine is an aminothiol that could act as an antioxidant scavenging hydroxyl radical, hypochlorous acid and hydrogen peroxide [4] , the physiological role of cysteamine remains unknown because conflicting evidences of its role in redox regulation have been reported. Administration of cystamine showed rapid cleavage into two cysteamine molecules and an increase of the cellular antioxidant L-cysteine in mouse model of Huntington's disease [1, 41] and GSH levels particularly in neuronal cells and tissues in mouse [3, 42] . On the other hand, pantetheinase-deficient mice exhibited higher GSH production, suggesting an inhibitory role of cysteamine in GSH synthesis [6] . Consistent with these results, our data demonstrated that cysteamine treatment suppresses cellular GSH production in rat duodenal epithelial cells as well as in specific cell-lines, indicating that intracellular GSH regulation is a critical determinant of cystamine cytotoxicity. Cysteamine is currently used to treat patients with nephropathic cystinosis. Recently, cystamine or cysteamine demonstrated beneficial effects in mouse models of Huntington's disease [8] , Parkinson's disease [10] , selenite-induced cataract formation [39] and bleomycininduced lung fibrosis [43] . The results described here suggest that these effects of cystamine should be carefully re-evaluated after longterm administration. Fig. 6 . Cystamine-induced AIF translocation depends on intracellular GSH levels. DU145 and HeLa cells were treated with GSH-EE (2.5 mM) and cystamine (500 μM) and immunostained with anti-AIF antibodies and FITC-conjugated goat anti-mouse IgG. Scale bar: 50 μm.
Intracellular GSH levels are modulated in multiple ways. At the transcriptional level, cellular GSH content is strictly regulated by GCS expression levels. GCS is a heterodimer that is composed of a catalytic (GCS C ) and modifier subunit (GCS M ). GCS C transcription is regulated by TPA and an electrophile response element, which are activated by AP-1 and Nrf2, respectively [21] . Cystamine treatment reportedly activated Nrf2 pathway both in cell culture and in brain tissue [42] . At the enzyme level, GCS C activity is increased by GCS M in response to oxidative insults, but is inhibited by GSH via negative feedback [44] . Moreover, GCS C is inhibited by cellular metabolite cysteamine through a sulfhydryl-disulfide interchange reaction between GCS C and cysteamine in vitro and in vivo [2, 6] . Thus, the decreased GCS C activity and expression in cystamine-treated cells as demonstrated in this study suggest that cystamine functions as a negative regulator to limit GSH production, which modulates cellular responses to external stress. Although NAC replenishes intracellular GSH by providing cysteine, the protective effect of NAC in cystamine cytotoxicity is probably attributed to a direct adduct formation and interference with cystamine, or substitute for the functions of GSH through its sulfhydryl group. In addition, our data also suggest that aberrant regulation of GSH level may contribute to the defective triggering of AIF nuclear translocation in response to various apoptotic stimuli. Therefore, regulation of intracellular GSH levels is an important point of control in AIF-mediated caspase-independent cell death.
AIF is an oxidoreductase located in the mitochondrial inner membrane which is essential for maintenance of the mitochondrial respiratory chain complex I and redox status [45] . AIF also mediates caspaseindependent cell death in response to alkylating agents, excitotoxins, hypoxia/ischemia and growth factor deprivation [28] . Our data demonstrated that GSH depletion triggers AIF nuclear translocation even in the absence of oxidative stress, indicating that GSH depletion is a downstream signal linking apoptotic stimuli with AIF nuclear translocation, but is not a simple marker of oxidative stress in the caspaseindependent cell death. In support of this notion, increased export of cellular GSH has been observed in AIF-mediated cell death induced by treatment with glutamate, N-methyl-D-aspartate, kainate, and hypoxia/ ischemia [46] [47] [48] . Moreover, our results also showed decreased total GSH in the cysteamine-treated duodenal mucosal cells in rats. These observations suggest that increased GSH efflux likely contributes to GSH depletion causing AIF-mediated cell death. Because GSH efflux is an active process regulating cellular redox homeostasis, GSH transporters such as multidrug resistance proteins, the organic anion transporter and the glutamate/aspartate transporter might play an important role in modulation of AIF-mediated cell death [49] . Thus, it will be of interest to elucidate the role of GSH transporters in AIF translocation that is induced by chemicals associated with cellular redox status and GSH level alterations including As 2 O 3 , cladribine, granulysin, geldanamycin, staurosporine, sulindac, camptothecin, hexaminolevulinate and DNA alkylating agents [28] . Moreover, GSH depletion is also required for caspase activation, apoptosome formation and cytosolic cytochrome c release, most likely through redox-based protein modifications such as glutathionylation and nitrosylation [22] . Therefore, GSH depletion may be involved in the regulation of caspase-independent and -dependent apoptosis.
The Harlequin (Hq) mouse is a strain that harbors an AIF gene insertion mutation resulting in an 80% reduction of AIF expression. Hq mice exhibited protection from ischemia-induced brain damage, and primary neuronal cells were resistant to hypoxia/ischemia-induced cell death [50] [51] [52] . However, Hq mice paradoxically developed age-associated cerebellum and retinal degeneration with increased lipid peroxide and 8-hydroxydeoxyguanine levels [22] , and cultured cerebellar granule cells from Hq mice were more sensitive to ROS-induced cell death than those from wild-type mice [53] . Our results may provide a molecular explanation for these contradictory phenotypes of Hq mice. We demonstrated that AIF-mediated cell death occurred under GSHdepleted conditions, suggesting that AIF functions as an eliminator of cells with low GSH content. Therefore, AIF-knockdown cells could survive even in low GSH levels in which wild-type cells undergo cell death, but these cells subsequently become dysfunctional due to the accumulation of oxidatively damaged molecule. Moreover, the defective complex I function in AIF-knockdown cells may also contribute to increased oxidative stress. Interestingly, AIF protein levels in the cortical Fig. 8 . Cysteamine induces AIF-mediated apoptosis through GSH depletion in a rat model of duodenal ulcer. (a) Total and reduced GSH levels in the proximal duodenal tissues after cysteamine administration. Duodenal ulcers were induced in female Sprague-Dawley rats by intragastric cysteamine administration. Three doses of cysteamine (25 mg/100 g body weight each time) were given at 4 h intervals, and GSH levels were estimated 10 and 24 h after the first dose of cysteamine. Asterisk indicates statistically significant difference (*p b 0.05). (b) AIF localization in cysteamine-treated rat duodenum. After cysteamine administration, duodenal tissues were immunostained with anti-AIF antibodies and FITC-conjugated goat anti-mouse IgG, and nuclei were counter-stained with DAPI. Scale bar: 20 μm. area of normal human brains reportedly increased with aging, but was lower in cortical brains from Alzheimer's disease patients compared with age-matched controls [54] , suggesting a role for AIF in the pathogenesis of neurodegenerative disease. However, further studies would be required to establish the cause-result relationship between AIF expression and neurodegeneration.
In summary, we demonstrated that cystamine-induced GSH depletion caused cell death by triggering AIF nuclear translocation in cellular and animal models. This is the first report on the molecular mechanism of cystamine toxicity and provides important implications for cystamine in neurodegenerative disease therapeutics. In addition, our data indicate that GSH may play a role in the regulation of AIF-mediated cell death as well as in the maintenance of redox homeostasis in response to oxidative stress. These results may provide new insights into the pathophysiological role of cysteamine, GSH and AIF in various diseases.
